Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis. - Wikidata - wikimedia - TriplyDB

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.

http://www.wikidata.org/entity/Q34854941

about

Bone Metastasis from Renal Cell Carcinoma High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review.Skeletal metastasis in renal cell carcinoma: A review.Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.Activated matriptase as a target to treat breast cancer with a drug conjugate.MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation.

P2860

Q26747493-2B5C1CD1-FF1B-4295-B948-2F7839671CE7 Q36162776-2A87010A-CBFD-45BF-A5F4-427511D14EF4 Q36847591-1DC394A2-5C16-4074-848C-AC9D1883C5F5 Q47103399-D3A6116C-F096-4646-BD56-BFE3F91D4B44 Q52670909-E869C94A-2792-4BFF-8BCF-DBC67F462631 Q53220940-20FB4751-EC18-4872-A206-03000ED50D6C Q54254288-96947947-8B0C-4D40-9583-C0F34BB9A4D3 Q55054374-45DFB079-9321-4852-AA49-DBBC75951BB2 Q55491411-DBB306D3-93B9-4988-94AE-534224AFAE87 Q55515387-E202E7FE-4037-4E65-9B2E-64A2BE4FBA51

P2860

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.

http://www.wikidata.org/entity/Q34854941

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Matriptase and MET are promine ...... immunohistochemical analysis.

@ast

Matriptase and MET are promine ...... immunohistochemical analysis.

@en

Matriptase and MET are promine ...... immunohistochemical analysis.

@nl

type

label

Matriptase and MET are promine ...... immunohistochemical analysis.

@ast

Matriptase and MET are promine ...... immunohistochemical analysis.

@en

Matriptase and MET are promine ...... immunohistochemical analysis.

@nl

prefLabel

Matriptase and MET are promine ...... immunohistochemical analysis.

@ast

Matriptase and MET are promine ...... immunohistochemical analysis.

@en

Matriptase and MET are promine ...... immunohistochemical analysis.

@nl

P1433

Q34854941-79D365C8-ABD5-4CDE-B613-D6F18AA1283D

P1476

Q34854941-A2DD5AA5-9EA1-4849-8E0E-EEDB1D0056EC

P2093

Q34854941-0C8DD787-5A44-4205-AF6F-9A9886302886

Q34854941-36BFE52A-81B5-46F4-9CBB-4CCF42BF5BFB

Q34854941-3855C0A5-59DA-4E2F-997B-16115BD60FE5

Q34854941-6B8D4D20-14A8-45E2-A38F-D0D52AD6A8E6

Q34854941-6FDDDDDD-F742-47C1-B49C-265585CD31B0

Q34854941-731B77F2-63B6-4CD5-910A-9A74B57C91A1

Q34854941-84088A62-34C2-424D-9732-17D498904F5E

Q34854941-B04A8F6F-CFC6-42E5-A7BE-A7A38218107F

Q34854941-C6E1FC2A-BC73-41A4-ACB0-6B777C194536

Q34854941-D9CF1E90-F0CE-476E-939B-A45F470FB4B3

P2860

Q34854941-0485B953-F016-494C-9A0D-5DAFFD565B36

Q34854941-16C4B1DE-50D7-4536-ABA3-A790B70576E6

Q34854941-1FE777C6-9846-4523-8F54-D3026F9EE934

Q34854941-25668E7B-23AD-4F84-AFB4-D5736A666086

Q34854941-2AF1C66B-922C-4E1F-AF5B-B30990EB9958

Q34854941-3F40A36C-98B1-485B-B5AC-A6D0BDF0DF5B

Q34854941-42913205-5466-49F4-8A48-81983C88404E

Q34854941-4F0D8B04-47F0-43E2-9F13-FA53ACF88829

Q34854941-55ABAEFF-6725-439C-8EE8-A255ECEB087D

Q34854941-62954A50-AD64-47B7-A4FF-28A8C7280C13

P2888

Q34854941-58A5B93F-4DE0-458F-B340-4FCAAFF3AC37

P304

Q34854941-C4F1DEEE-1834-4738-A6FE-D1AC817A9C16

P31

Q34854941-5C480B12-F1CF-4B5A-8606-B0057D889891

P356

Q34854941-607CFAE5-6E3B-4AB8-A6D4-5571641FB95D

P433

Q34854941-26A81156-1E32-430A-B729-2B6E5EA3CD23

P478

Q34854941-4FFED254-E538-4D47-BAFC-54A7DB0EDA11

P577

Q34854941-1633AA07-691D-4CA3-8468-39BFDAC4AC00

P5875

Q34854941-496C97B0-1D80-4113-81FA-F16F9FB15F0E

P6179

Q34854941-86F04BDA-54E7-42D1-9724-20E3E75688D2

P698

Q34854941-DBF1A2E4-6746-4102-9209-55ED79839A4A

P921

Q34854941-6C3B60CE-A175-4D81-A7BF-1398322AE062

P932

Q34854941-BFA4632C-EF09-4DD0-B78D-636D3B46FAA6

P356

S13577-014-0101-3

P1433

P1476

Matriptase and MET are promine ...... immunohistochemical analysis.

@en

P2093

Hiroaki Kataoka

http://www.w3.org/2001/XMLSchema#string

Hiromasa Tukino

http://www.w3.org/2001/XMLSchema#string

Kenji Yorita

http://www.w3.org/2001/XMLSchema#string

Kozue Nakahara

http://www.w3.org/2001/XMLSchema#string

Satoru Sugie

http://www.w3.org/2001/XMLSchema#string

Shoichiro Mukai

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Kamoto

http://www.w3.org/2001/XMLSchema#string

Toyoharu Kamibeppu

http://www.w3.org/2001/XMLSchema#string

Yuichi Katayama

http://www.w3.org/2001/XMLSchema#string

Yukari Kawagoe

http://www.w3.org/2001/XMLSchema#string

P2860

Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model

The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.

High expression of the Met receptor in prostate cancer metastasis to bone.

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Renal cell carcinoma bone metastases: clinical advances

Matriptase: potent proteolysis on the cell surface.

Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.

Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway

The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans

Type II transmembrane serine proteases in development and disease.

P2888

s13577-014-0101-3

P304

44-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13577-014-0101-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265342182

http://www.w3.org/2001/XMLSchema#string

P6179

1029354047

http://www.w3.org/2001/XMLSchema#string

P698

25186085

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

4286132

http://www.w3.org/2001/XMLSchema#string